Skip to content
2000
Volume 20, Issue 2
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Sodium oxybate (SO) has been in use for many decades to treat narcolepsy with cataplexy. It functions as a weak GABAB agonist but also as an energy source for the brain as a result of its metabolism to succinate and as a powerful antioxidant because of its capacity to induce the formation of NADPH. Its actions at thalamic GABAB receptors can induce slow-wave activity, while its actions at GABAB receptors on monoaminergic neurons can induce or delay REM sleep. By altering the balance between monoaminergic and cholinergic neuronal activity, SO uniquely can induce and prevent cataplexy. The formation of NADPH may enhance sleep’s restorative process by accelerating the removal of the reactive oxygen species (ROS), which accumulate during wakefulness. SO improves alertness in normal subjects and in patients with narcolepsy. SO may allay severe psychological stress - an inflammatory state triggered by increased levels of ROS and characterized by cholinergic supersensitivity and monoaminergic deficiency. SO may be able to eliminate the inflammatory state and correct the cholinergic/ monoaminergic imbalance.

Loading

Article metrics loading...

/content/journals/cn/10.2174/1570159X19666210407151227
2022-02-01
2024-12-25
Loading full text...

Full text loading...

/content/journals/cn/10.2174/1570159X19666210407151227
Loading

  • Article Type:
    Review Article
Keyword(s): depression; narcolepsy; oxidative stress; Sleep; sleep homeostasis; sodium oxybate
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test